Clinical trial
An Open-Label Phase 2 Study of ManNAc in Subjects With GNE Myopathy
NCT02346461 is registered in ClinicalTrials.gov with National Human Genome Research Institute (NHGRI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Phase 2 Study of ManNAc in Subjects With GNE Myopathy
- Lead sponsor
- National Human Genome Research Institute (NHGRI)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 5, 2015
- Completion date
- November 15, 2018
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gne myopathy